Mobidiag
Espoo
About Mobidiag
Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $74.1M
- Funding stage: M&A
- Last round: Debt Financing (Jan 2020)
- Website: mobidiag.com
- Phone: +358105050770
Industries & Categories
Biotechnology, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/mobidiag-34303 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.